AXXZIA, Inc. (JP:4936)
:4936
Top Page
AXXZIA, Inc.
(4936)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥336.00
▼(-14.29% Downside)
Action:ReiteratedDate:03/24/26
The score is anchored by stable financial footing (low leverage) and positive, improving free cash flow, but is held back by sharp margin compression in 2025 and clear bearish technical signals (below major moving averages and negative MACD). Dividend yield provides some support, while negative P/E reflects weak current earnings.
Positive Factors
Low Leverage / Strong Balance Sheet
A conservatively financed balance sheet with debt-to-equity ~0.11 and a sizable equity base provides durable financial flexibility. Over the next 2–6 months this supports investment in product development, distributor relationships and cushions operational stress without needing external financing.
Negative Factors
Sharp Margin Compression
Rapid decline in net and operating margins reflects rising costs below gross profit or structural expense pressure. If sustained, compressed profitability will erode return on capital, limit reinvestment capacity, and may force pricing or cost restructuring to restore durable margins.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Balance Sheet
A conservatively financed balance sheet with debt-to-equity ~0.11 and a sizable equity base provides durable financial flexibility. Over the next 2–6 months this supports investment in product development, distributor relationships and cushions operational stress without needing external financing.
Read all positive factors
AXXZIA, Inc. (4936) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.39B
Dividend Yield2.65%
Average Volume (3M)33.33K
Price to Earnings (P/E)―
Beta (1Y)1.13
Revenue Growth11.87%
EPS Growth-31.02%
CountryJP
Employees258
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-1.95
Shares Outstanding24,107,000
10 Day Avg. Volume32,930
30 Day Avg. Volume33,333
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)1.38
Price to Sales (P/S)0.77
P/FCF Ratio16.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)15.7
Revenue Forecast (FY)¥14.00B
AXXZIA, Inc. Business Overview & Revenue Model
Company Description
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, makeup, skincare, body care, supplements, salon care, and homecare products under the AXXZIA, AGtheory, LisBeau, Venus Recipe, The B, Le Ciel de L'a...
AXXZIA, Inc. Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
78
Positive
Cash Flow
61
Positive
| Breakdown | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.48B | 12.19B | 11.34B | 8.22B | 5.79B |
| Gross Profit | 9.92B | 9.61B | 8.94B | 6.22B | 4.08B |
| EBITDA | 746.64M | 1.29B | 2.06B | 1.84B | 1.40B |
| Net Income | 354.28M | 794.35M | 1.33B | 1.12B | 868.64M |
Balance Sheet | |||||
| Total Assets | 9.62B | 10.54B | 10.70B | 10.05B | 8.27B |
| Cash, Cash Equivalents and Short-Term Investments | 3.99B | 4.93B | 5.79B | 6.39B | 5.94B |
| Total Debt | 860.67M | 975.56M | 632.25M | 654.12M | 213.64M |
| Total Liabilities | 2.04B | 2.01B | 1.80B | 1.66B | 1.07B |
| Stockholders Equity | 7.57B | 8.53B | 8.90B | 8.40B | 7.19B |
Cash Flow | |||||
| Free Cash Flow | 640.22M | 410.77M | 282.75M | 732.86M | 984.56M |
| Operating Cash Flow | 781.65M | 800.36M | 707.85M | 797.69M | 1.06B |
| Investing Cash Flow | -158.54M | -626.66M | -438.69M | -775.36M | -84.51M |
| Financing Cash Flow | -1.48B | -1.55B | -862.75M | 386.43M | 3.96B |
AXXZIA, Inc. Technical Analysis
Neutral
392.00
Price Trends
363.90
Negative
381.97
Negative
418.88
Negative
Market Momentum
-3.95
Negative
49.49
Neutral
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4936, the sentiment is Neutral. The current price of 392 is above the 20-day moving average (MA) of 342.25, above the 50-day MA of 363.90, and below the 200-day MA of 418.88, indicating a neutral trend. The MACD of -3.95 indicates Negative momentum. The RSI at 49.49 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4936.
AXXZIA, Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥6.52B | 12.52 | ― | 2.38% | -0.79% | ― | |
68 Neutral | ¥2.23B | 3.43 | ― | 1.72% | -6.06% | -97.12% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ¥8.39B | -49.92 | ― | 2.65% | 11.87% | -31.02% | |
58 Neutral | ¥5.39B | -33.12 | ― | 1.68% | 8.46% | ― | |
52 Neutral | ¥5.21B | 42.42 | ― | ― | -19.42% | ― | |
51 Neutral | ¥1.93B | -3.04 | ― | ― | 12.96% | ― |
* Consumer Defensive Sector Average
JP:4936
AXXZIA, Inc.
348.00
-38.93
-10.06%
JP:4918
Ivy Cosmetics Corporation
340.00
95.87
39.27%
JP:4920
Nippon Shikizai, Inc.
1,063.00
113.08
11.90%
JP:4925
HABA Laboratories, Inc.
1,723.00
99.89
6.15%
JP:4926
C'BON COSMETICS Co., Ltd.
1,260.00
167.33
15.31%
JP:4934
Premier Anti-Aging Co., Ltd.
597.00
-183.00
-23.46%
AXXZIA, Inc. Corporate Events
AXXZIA Posts Higher Sales but First-Half Profit Slumps, Keeps Full-Year Outlook Intact
Mar 13, 2026
AXXZIA Inc. reported first-half fiscal 2026 consolidated net sales of ¥6.77 billion, up 7.8% year on year, but slipped to a slight operating loss as ordinary income and profit attributable to owners of parent fell sharply amid rising costs. D...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.